Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Influenza vaccine 2 by Johnson & Johnson for Unspecified Influenza Virus Infections: Likelihood of Approval
Influenza vaccine 2 is under clinical development by Johnson & Johnson and currently in Phase II for Unspecified Influenza Virus...